CHK2 |
nucleus |
responses to genotoxic stress |
mutation or low expression in breast, prostate, ovarian, colon, kidney, thyriod, bladder, lung cancer as well as sarcomas and leukemias |
67 |
CK2 |
nucleus |
promotes cell proliferation and growth, suppresses cell apoptosis |
overexpression or hyperactivation in lung, breast, prostate, gastric, kidney cancer as well as AML, CLL and lymphomas |
81; 90 |
cyclin L1 |
nucleus |
regulates transcription and RNA splicing |
overexpressed in human head and neck cancer, and is associated with lymph node metastases, also amplify in uterine cervical carcinoma and associates with poor prognosis |
59; 61; 88 |
cyclin L2 |
nucleus |
functions as a regulator of the pre-mRNA splicing process, modulates the expression of apoptotic and antiapoptotic proteins |
overexpression of cyclin L2 inhibits cancer cell growth, induces apoptosis and cell cycle arrest, and enhances chemosensitivity |
59; 61; 89 |
cyclin D3 |
nucleus and cytoplasm |
forms a complex with CDK4 or CDK6, phosphorylates and inhibits RB protein and regulates the cell cycle G1/S transition |
overexpressed and associated with a worse prognosis in patients with malignant melanoma, breast cancer, and non-Hodgkin's lymphoma |
78 |
RNPS1 |
nucleus |
regulates RNA splicing, promotes mRNA nuclear export and translation, as well as maintenance of postsplicing surveillance |
overexpressed in mouse submandibular gland adenocarcinoma |
60; 65 |
9G8 |
nucleus and cytoplasm |
regulates RNA splicing, promotes nucleocytoplasmic export of mRNA and translate |
not confirmed |
60 |
ELL2 |
nucleus |
promotes transcription initiation and elongation, directs immunoglobulin secretion, inhibits cell growth and survival, induces cell cycle arrest and apoptosis |
increased expression in leukemia, mutation associated with multiple myeloma and salivary gland carcinoma |
45 |
TFIIF |
nucleus and cytoplasm |
promotes transcription elongation by interacting with RNAPII throughout the elongation phase |
unknown |
45 |
TFIIS |
nucleus and cytoplasm |
promotes transcription elongation by enhancing the intrinsic endonucleolytic cleavage activity of RNAPII |
unknown |
45 |
FACT |
nucleus |
modulates nucleosome stability and chromatin remodeling, promotes DNA replication, recombination, and repair, as well as transcript elongation |
overexpressed in breast carcinoma, non-small-cell lung cancer, renal cell carcinoma, and prostatic, pancreatic, and colorectal adenocarcinomas |
45 |
RBM15B/OTT3 |
nucleus and cytoplasm |
inhibits spliceosomal E complex formation, regulates RNA splicing and mRNA export |
unknown |
68 |
14-3-3 |
nucleus |
regulates cell cycle, protein trafficking, and steroidogenesis, promotes cell proliferation, inhibits cell apoptosis |
overexpressed in breast, lung, liver, head and neck cancers, as well as glioma and astrocytoma |
94 |
Hsp90 |
cytoplasm and cell membrane |
maintains normal tissue homeostasis |
overexpression and/or hyperactivation in almost all human cancers |
93 |
Sufu |
nucleus and cytoplasm |
promotes embryonic development |
deletion, mutation or underexpression in lung, breast, prostate cancer, as well as in medulloblastoma |
91; 92 |